Synthace

The UK’s first dedicated synthetic biology company with a world leading platform of technologies for the rapid engineering and optimisation of novel biological production systems. A spin out of University College London, Synthace is already producing high-value research and development products for the pharmaceutical, agrochemical and fine chemicals industry. Synthace bioengineering is enabled by a tight integration of computational modelling and big data analysis with wet lab experimental design and validation, and novel molecular biology tools. While Synthace bioengineering is broadly applicable across multiple industry sectors, the company is focused towards applications in the production of specialty chemicals.
Company Growth (employees)
Type
Private
HQ
London, GB
Founded
2011
Size (employees)
27 (est)
Synthace was founded in 2011 and is headquartered in London, GB

Key People at Synthace

Tim Fell

Tim Fell

CEO
Christopher Grant Ward

Christopher Grant Ward

Co-Founder
Markus Gershater

Markus Gershater

CSO
Sean Ward

Sean Ward

Founder and CTO

Synthace Office Locations

Synthace has an office in London
London, GB (HQ)
2 Royal College St

Synthace Metrics

Summary Metrics

Founding Date

2011

Total Funding

$2.9 m

Latest funding size

$1.9 m

Time since last funding

over 3 years

Investors

Synthace's latest funding round in September 2013 was reported to be $1.9 m. In total, Synthace has raised $2.9 m

Synthace Online Presence

Synthace Company Life

You may also be interested in